IBEX Limited
IBEX
$23.34
-$1.06-4.34%
| Weiss Ratings | IBEX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Excellent | |||
| Risk Index | Weak | |||
| Risk Grade | D+ | |||
| Reward Grade | A- | |||
| Rating Factors | IBEX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Good | |||
| Efficiency Index | Excellent | |||
| Solvency Index | Excellent | |||
| Total Return Index | Good | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | IBEX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.09 | |||
| Price History | IBEX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -7.64% | |||
| 30-Day Total Return | -9.15% | |||
| 60-Day Total Return | 8.56% | |||
| 90-Day Total Return | 10.46% | |||
| Year to Date Total Return | 7.56% | |||
| 1-Year Total Return | 64.37% | |||
| 2-Year Total Return | -6.68% | |||
| 3-Year Total Return | 55.08% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -12.32% | |||
| 52-Week Low % Change | 87.69% | |||
| Price | IBEX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $27.83 | |||
| 52-Week Low Price | $13.00 | |||
| 52-Week Low Price (Date) | Apr 25, 2024 | |||
| 52-Week High Price (Date) | Feb 14, 2025 | |||
| Valuation | IBEX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 321.88M | |||
| Enterprise Value | 396.08M | |||
| Price/Earnings (TTM) | 11.49 | |||
| Earnings Per Share (TTM) | 2.12 | |||
| Earnings Per Share Growth | 37.83% | |||
| Price/Earnings To Growth | 0.30 | |||
| Price/Sales (TTM) | 0.77 | |||
| Price/Book (Q) | 2.95 | |||
| Enterprise Value/Revenue (TTM) | 0.76 | |||
| Price | $23.34 | |||
| Enterprise Value/EBITDA (TTM) | 5.97 | |||
| Enterprise Value/EBIT | 8.22 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | IBEX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 16.46M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | IBEX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 202 580 6200 | |||
| Address | 1717 Pennsylvania Avenue NW Washington, DC 20006 | |||
| Website | www.ibex.co | |||
| Country | United States | |||
| Year Founded | 2017 | |||
| Profitability | IBEX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 9.23% | |||
| Profit Margin | 7.08% | |||
| Management Effectiveness | IBEX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 10.56% | |||
| Return on Equity | 27.88% | |||
| Income Statement | IBEX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 521.73M | |||
| Total Revenue (TTM) | 521.73M | |||
| Revenue Per Share | $31.70 | |||
| Gross Profit (TTM) | 160.67M | |||
| EBITDA (TTM) | 66.33M | |||
| EBIT (TTM) | 48.20M | |||
| Net Income (TTM) | 36.95M | |||
| Net Income Avl. to Common (TTM) | 36.95M | |||
| Total Revenue Growth (Q YOY) | 6.07% | |||
| Earnings Growth (Q YOY) | 52.56% | |||
| EPS Diluted (TTM) | 2.12 | |||
| EPS Diluted Growth (Q YOY) | 72.73% | |||
| Balance Sheet | IBEX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 20.21M | |||
| Cash Per Share (Q) | $1.23 | |||
| Total Current Assets (Q) | 159.02M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 108.94M | |||
| Current Ratio (Q) | 1.437 | |||
| Book Value Per Share (Q) | $8.26 | |||
| Total Assets (Q) | 272.50M | |||
| Total Current Liabilities (Q) | 110.64M | |||
| Total Debt (Q) | 94.41M | |||
| Total Liabilities (Q) | 163.56M | |||
| Total Common Equity (Q) | 108.94M | |||
| Cash Flow | IBEX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -11.86M | |||
| Cash from Financing (TTM) | -54.71M | |||
| Net Change in Cash (TTM) | -28.81M | |||
| Levered Free Cash Flow (TTM) | 25.81M | |||
| Cash from Operations (TTM) | 37.76M | |||
